CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia

Animesh Pardanani(Mayo Clinic in Arizona), Terra L. Lasho(Mayo Clinic in Arizona), Rebecca R. Laborde(Mayo Clinic in Arizona), Michelle A. Elliott(Mayo Clinic in Arizona), C. Hanson(Mayo Clinic in Arizona), Ryan A. Knudson(Mayo Clinic in Arizona), Rhett P. Ketterling(Mayo Clinic in Arizona), Julia E. Maxson(Oregon Health & Science University), Jeffrey Tyner(OHSU Knight Cancer Institute), A Tefferi(Mayo Clinic in Arizona)
Leukemia
April 22, 2013
10.1038/leu.2013.122
Cited by 248Open Access
Full Text

Abstract

Related Papers

The Granulocyte-Macrophage Colony-Stimulating Factors
Donald Metcalf|Science|1985|1k
Oncogenic<i>CSF3R</i>Mutations in Chronic Neutrophilic Leukemia and Atypical CML
Julia E. Maxson, Jason Gotlib, Daniel A. Pollyea et al.|New England Journal of Medicine|2013|563
Recurrent SETBP1 mutations in atypical chronic myeloid leukemia
Rocco Piazza, Simona Valletta, Nils Winkelmann et al.|Nature Genetics|2012|424
Distinct cytoplasmic regions of the human granulocyte colony-stimulating factor receptor involved in induction of proliferation and maturation.
Fan Dong, C van Buitenen, K Pouwels et al.|Molecular and Cellular Biology|1993|240
Safety and efficacy of CYT387, a JAK1 and JAK2 inhibitor, in myelofibrosis
Animesh Pardanani, Rebecca R. Laborde, Terra L. Lasho et al.|Leukemia|2013|229